Risks thrombolytic therapy. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Iliac Vein Coronary Vessels Middle Cerebral Artery Brain Carotid Artery, Internal

Organisms1

Diseases39

Myocardial Infarction Stroke Pulmonary Embolism Brain Ischemia Cerebral Hemorrhage Thrombosis Acute Disease Heart Rupture, Post-Infarction Intracranial Thrombosis Hemorrhage Intracranial Hemorrhages Carotid Artery Thrombosis Coronary Thrombosis Recurrence Intracranial Embolism and Thrombosis Emergencies Intracranial Embolism Venous Thrombosis Cerebral Infarction Eye Hemorrhage Heart Rupture Ecchymosis Infarction, Middle Cerebral Artery Cerebrovascular Disorders Arterial Occlusive Diseases Shock, Cardiogenic Ventricular Septal Rupture Infarction, Anterior Cerebral Artery Thrombophlebitis Embolism Ventricular Dysfunction, Right Heart Diseases Thromboembolism Heart Block Coronary Disease Disease Models, Animal Ischemia Arrhythmias, Cardiac Constriction, Pathologic

Chemicals and Drugs25

Streptokinase Tissue Plasminogen Activator Fibrinolytic Agents Plasminogen Activators Anistreplase Urokinase-Type Plasminogen Activator Heparin Fibrinolysin Recombinant Proteins Anticoagulants Creatine Kinase Fibrinopeptide A Fibrinogen Fibrin Streptodornase and Streptokinase Aspirin Fibrin Fibrinogen Degradation Products Plasminogen Hirudins Platelet Aggregation Inhibitors Antifibrinolytic Agents Thrombin Thallium Radioisotopes Immunoglobulin Fab Fragments Metoprolol

Analytical, Diagnostic and Therapeutic Techniques and Equipment66

Thrombolytic Therapy Treatment Outcome Myocardial Reperfusion Embolectomy Electrocardiography Angioplasty, Balloon, Coronary Infusions, Intravenous Prospective Studies Coronary Angiography Injections, Intravenous Infusions, Intra-Arterial Tomography, X-Ray Computed Hirudin Therapy Emergency Treatment Radionuclide Ventriculography Retrospective Studies Hospital Mortality Injections, Intra-Arterial Thrombectomy Reperfusion Cerebral Angiography Follow-Up Studies Patient Selection Randomized Controlled Trials as Topic Catheterization, Peripheral Survival Analysis Angiography Predictive Value of Tests Risk Factors Drug Therapy, Combination Prognosis Cardiac Catheterization Registries Survival Rate Multivariate Analysis Vena Cava Filters Stroke Volume Severity of Illness Index Catheterization Magnetic Resonance Imaging Hospitalization Angioplasty, Balloon Incidence Logistic Models Heart Valve Prosthesis Double-Blind Method Intra-Aortic Balloon Pumping Clinical Trials as Topic Fibrin Clot Lysis Time Treatment Failure Magnetic Resonance Angiography Ultrasonic Therapy Tomography, Emission-Computed, Single-Photon Drug Administration Schedule Ultrasonography, Doppler, Transcranial Echocardiography Length of Stay Combined Modality Therapy Coronary Artery Bypass Disease Models, Animal Sensitivity and Specificity Regression Analysis Diffusion Magnetic Resonance Imaging Stents Risk Assessment Neurologic Examination

Phenomena and Processes12

Time Factors Fibrinolysis Vascular Patency Blood Coagulation Hemostasis Ventricular Function, Left Stroke Volume Coronary Circulation Cerebrovascular Circulation Fibrin Clot Lysis Time Platelet Aggregation Sensitivity and Specificity

Disciplines and Occupations1

Community Medicine

Information Science4

Hospital Mortality Registries Survival Rate Incidence

Named Groups1

Emergency Medical Technicians

Health Care34

Treatment Outcome Coronary Care Units Prospective Studies Emergency Medical Services Emergencies Emergency Medical Technicians Retrospective Studies Hospital Mortality Follow-Up Studies Patient Selection Randomized Controlled Trials as Topic Survival Analysis Predictive Value of Tests Risk Factors Hospitals, Community Registries Survival Rate Multivariate Analysis Severity of Illness Index Emergency Service, Hospital Hospitalization Incidence Logistic Models Double-Blind Method Clinical Trials as Topic Age Factors Treatment Failure Confounding Factors (Epidemiology)Length of Stay Drug Utilization Sensitivity and Specificity Regression Analysis Physician's Practice Patterns Risk Assessment

Geographicals1

Newfoundland and Labrador

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Thrombolytic Therapy Streptokinase Tissue Plasminogen Activator Fibrinolytic Agents Myocardial Infarction Plasminogen Activators Anistreplase Urokinase-Type Plasminogen Activator Stroke Pulmonary Embolism Brain Ischemia Treatment Outcome Heparin Cerebral Hemorrhage Myocardial Reperfusion Time Factors Embolectomy Thrombosis Acute Disease Coronary Care Units Fibrinolysis Heart Rupture, Post-Infarction Intracranial Thrombosis Hemorrhage Electrocardiography Intracranial Hemorrhages Angioplasty, Balloon, Coronary Fibrinolysin Carotid Artery Thrombosis Infusions, Intravenous Prospective Studies Coronary Thrombosis Coronary Angiography Emergency Medical Services Recurrence Intracranial Embolism and Thrombosis Injections, Intravenous Recombinant Proteins Vascular Patency Emergencies Infusions, Intra-Arterial Tomography, X-Ray Computed Intracranial Embolism Venous Thrombosis Cerebral Infarction Hirudin Therapy Emergency Treatment Anticoagulants Creatine Kinase Emergency Medical Technicians Radionuclide Ventriculography Retrospective Studies Hospital Mortality Injections, Intra-Arterial Thrombectomy Reperfusion Fibrinopeptide A Cerebral Angiography Follow-Up Studies Fibrinogen Fibrin Eye Hemorrhage Patient Selection Newfoundland and Labrador Heart Rupture Randomized Controlled Trials as Topic Catheterization, Peripheral Streptodornase and Streptokinase Survival Analysis Aspirin Angiography Ecchymosis Predictive Value of Tests Infarction, Middle Cerebral Artery Risk Factors Cerebrovascular Disorders Drug Therapy, Combination Blood Coagulation Prognosis Arterial Occlusive Diseases Fibrin Fibrinogen Degradation Products Hospitals, Community Cardiac Catheterization Shock, Cardiogenic Ventricular Septal Rupture Plasminogen Infarction, Anterior Cerebral Artery Registries Survival Rate Multivariate Analysis Iliac Vein Hemostasis Vena Cava Filters Hirudins Thrombophlebitis Community Medicine Platelet Aggregation Inhibitors Embolism Ventricular Dysfunction, Right Ventricular Function, Left

No FAQ available that match "risks thrombolytic therapy"